If you've noticed shifts in your cycle or unexpected physical changes, it could be perimenopause.

Misinformation around menopause is still frustratingly common—among both doctors and patients. We asked experts why you ...

Subcutaneous anifrolumab is superior to placebo in multiple systemic lupus erythematosus disease activity measures at 52 ...

Black History Month serves as a reminder to actively amplify Black voices, share stories and raise awareness throughout the year. This month, we’re featuring Danielle Storr, a Black lupus warrior who ...

There is no cure for measles. Doctors can provide supportive care and try to manage the symptoms — reduce fever, prevent dehydration, treat secondary bacterial infections — until the disease has run ...

Columnist Candace Semien reflects on the hardships faced by those in the lupus community, particularly as a result of lupus flares.

The Lupus Research Alliance applauds the decision by the U.S. Food and Drug Administration (FDA) to grant Breakthrough Therapy designation for litifilimab (BIIB059) in clinical development by Biogen ...

Litifilimab has the potential to be a first-in-class therapy targeting blood dendritic cell antigen 2 (BDCA2) in CLE, a chronic autoimmune skin disease that has a substantial impact on the daily life ...